找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Drug Resistance in Leukemia and Lymphoma III; G. J. L. Kaspers,R. Pieters,A. J. P. Veerman Book 1999 The Editor(s) (if applicable) and The

[复制链接]
楼主: lexicographer
发表于 2025-3-25 07:19:52 | 显示全部楼层
发表于 2025-3-25 10:48:34 | 显示全部楼层
发表于 2025-3-25 14:11:31 | 显示全部楼层
https://doi.org/10.1007/978-3-322-85040-9ence (NF), is related to cell compounds, i.e. proteins (1), nicotinic coenzymes (2), flavins (3), etc., engaged in structural and metabolic processes. Thus a correlation does exist between NF emission and morpho-functional state of cells.
发表于 2025-3-25 18:06:26 | 显示全部楼层
发表于 2025-3-25 21:32:25 | 显示全部楼层
发表于 2025-3-26 03:21:09 | 显示全部楼层
发表于 2025-3-26 05:39:04 | 显示全部楼层
Multidrug Resistance Related Proteins in Primary Cutaneous Lymphomas then polychemotherapy is indicated. Multi-agent chemotherapy may induce long lasting complete remissions in CBCL’s. Most CTCL’s, especially mycosis fungoides (MF), and CD30 negative primary cutaneous large T-cell lymphoma (PCLTCL) respond poorly or partially to Multi-agent Chemotherapy.
发表于 2025-3-26 09:20:58 | 显示全部楼层
Book 1999e protein), and the role of glutathione and glutathione-S-transferases. Moreover, more drug type-specific mechanisms of resistance are a topic, such as for glucocorticoids and antifolates. Much in­ formation is provided on apoptosis and its regulators, and on the results of cell culture drug resista
发表于 2025-3-26 14:41:09 | 显示全部楼层
https://doi.org/10.1007/978-94-015-9325-0ug resistance: (i) using multivariate analysis, MDR1 phenotype appears to be an independent variable, as potent (or higher) as karyo-type and age for predicting . drug resistance; (ii) the prognostic value is limited to the CD34(+)/P-gp(+) phenotype, wich is linked to a functional P-gp; (iii) the .
发表于 2025-3-26 17:11:03 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-14 21:52
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表